Cargando…
A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases
BACKGROUND: The lack of sufficient specificity and sensitivity among conventional cancer biomarkers, such as prostate specific antigen (PSA) for prostate cancer has been widely recognized after several decades of clinical implications. Autoantibodies (autoAb) among others are being extensively inves...
Autores principales: | Xie, Chong, Kim, Hyun J, Haw, Jonathan G, Kalbasi, Anusha, Gardner, Brian K, Li, Gang, Rao, Jianyu, Chia, David, Liong, Monty, Punzalan, Rubio R, Marks, Leonard S, Pantuck, Allan J, de la Taille, Alexandre, Wang, Guomin, Mukouyama, Hideki, Zeng, Gang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102624/ https://www.ncbi.nlm.nih.gov/pubmed/21504557 http://dx.doi.org/10.1186/1479-5876-9-43 |
Ejemplares similares
-
The influence of PSA autoantibodies in prostate cancer patients: a prospective clinical study-II
por: Nakajima, Kosei, et al.
Publicado: (2016) -
Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
por: Zhang, Cong, et al.
Publicado: (2021) -
Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes
por: Savvateeva, Elena N., et al.
Publicado: (2021) -
Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019) -
1601. Evaluation of Synergy with β-Lactams Plus Aztreonam Against Pseudomonas aeruginosa (PSA)
por: O’Donnell, J Nicholas, et al.
Publicado: (2019)